Cite

HARVARD Citation

    Blanchard, S. et al. (2019). High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease. British journal of dermatology. pp. 869-871. [Online]. 
  
Back to record